SCHEMBL30801758

SCHEMBL30801758

O=C1[C@H]2CNCCN2CCN1c1cc(-c2ccc(Cl)cc2)ncn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.39
KMO O15229 1/20 0.36
HTR2C P28335 1/20 0.35
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 1/20 0.32
USP30 Q70CQ3 1/20 0.32
ALDH1A1 P00352 2/20 0.32
POLB P06746 1/20 0.32
CYP1A2 P05177 2/20 0.32
HRH4 Q9H3N8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
IDH1 O75874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801868 0.89 DPP4 (0.42) DPP4KMOHTR2CSMN1; SMN2USP30
SCHEMBL30801797 0.81 GRM5 (0.47) DPP4USP30ALDH1A1CYP1A2HSD17B10
SCHEMBL23574136 0.79 USP30 (0.46) DPP4KMONPC1RAB9ASMN1; SMN2
SCHEMBL23574139 0.79 USP30 (0.46) DPP4KMONPC1RAB9ASMN1; SMN2
SCHEMBL30801870 0.79 GRM5 (0.48) DPP4USP30CYP1A2
SCHEMBL30801719 0.79 DRD2 (0.37) HTR2CNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL30801763 0.77 NPC1 (0.45) NPC1RAB9ASMN1; SMN2TSHRLMNA
SCHEMBL30801761 0.73 COMT (0.38) HTR2CUSP30
SCHEMBL30801833 0.71 F10 (0.40) HTR2C
SCHEMBL30801844 0.71 DRD2 (0.49) HTR2CSMN1; SMN2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 EP claimed